These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cidofovir: a review of its use in cytomegalovirus retinitis in patients with AIDS. Plosker GL, Noble S. Drugs; 1999 Aug; 58(2):325-45. PubMed ID: 10473024 [Abstract] [Full Text] [Related]
3. Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial. Lalezari JP, Stagg RJ, Kuppermann BD, Holland GN, Kramer F, Ives DV, Youle M, Robinson MR, Drew WL, Jaffe HS. Ann Intern Med; 1997 Feb 15; 126(4):257-63. PubMed ID: 9036797 [Abstract] [Full Text] [Related]
4. Clinical experience with cidofovir in the treatment of cytomegalovirus retinitis. Lalezari JP, Kuppermann BD. J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Feb 15; 14 Suppl 1():S27-31. PubMed ID: 9058615 [Abstract] [Full Text] [Related]
6. Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial. A randomized, controlled trial. Studies of Ocular complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group. Ann Intern Med; 1997 Feb 15; 126(4):264-74. PubMed ID: 9036798 [Abstract] [Full Text] [Related]
7. Long-term follow-up of patients with AIDS treated with parenteral cidofovir for cytomegalovirus retinitis: the HPMPC Peripheral Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. AIDS; 2000 Jul 28; 14(11):1571-81. PubMed ID: 10983644 [Abstract] [Full Text] [Related]
8. Cidofovir in the treatment of cytomegaloviral disease. Kendle JB, Fan-Havard P. Ann Pharmacother; 1998 Nov 28; 32(11):1181-92. PubMed ID: 9825085 [Abstract] [Full Text] [Related]
12. Clinical failure of CMV retinitis with intravitreal cidofovir is associated with antiviral resistance. Smith IL, Taskintuna I, Rahhal FM, Powell HC, Ai E, Mueller AJ, Spector SA, Freeman WR. Arch Ophthalmol; 1998 Feb 28; 116(2):178-85. PubMed ID: 9488269 [Abstract] [Full Text] [Related]
14. Pharmacokinetics and renal effects of cidofovir with a reduced dose of probenecid in HIV-infected patients with cytomegalovirus retinitis. Wolf DL, Rodríguez CA, Mucci M, Ingrosso A, Duncan BA, Nickens DJ. J Clin Pharmacol; 2003 Jan 28; 43(1):43-51. PubMed ID: 12520627 [Abstract] [Full Text] [Related]
15. In vitro antiviral susceptibilities of isolates from cytomegalovirus retinitis patients receiving first- or second-line cidofovir therapy: relationship to clinical outcome. Cherrington JM, Fuller MD, Lamy PD, Miner R, Lalezari JP, Nuessle S, Drew WL. J Infect Dis; 1998 Dec 28; 178(6):1821-5. PubMed ID: 9815243 [Abstract] [Full Text] [Related]
16. Cidofovir in the treatment of cytomegalovirus (CMV) retinitis. Garcia CR, Torriani FJ, Freeman WR. Ocul Immunol Inflamm; 1998 Sep 28; 6(3):195-203. PubMed ID: 9785611 [No Abstract] [Full Text] [Related]
17. Intravitreal cidofovir for the maintenance treatment of cytomegalovirus retinitis. Rahhal FM, Arevalo JF, Munguia D, Taskintuna I, Chavez de la Paz E, Azen SP, Freeman WR. Ophthalmology; 1996 Jul 28; 103(7):1078-83. PubMed ID: 8684797 [Abstract] [Full Text] [Related]
18. Cidofovir approved. PI Perspect; 1996 Sep 28; (No 19):14-5. PubMed ID: 11363898 [Abstract] [Full Text] [Related]
19. Incidence of foscarnet resistance and cidofovir resistance in patients treated for cytomegalovirus retinitis. The Cytomegalovirus Retinitis and Viral Resistance Study Group. Jabs DA, Enger C, Forman M, Dunn JP. Antimicrob Agents Chemother; 1998 Sep 28; 42(9):2240-4. PubMed ID: 9736542 [Abstract] [Full Text] [Related]
20. Cidofovir. Review of current and potential clinical uses. Safrin S, Cherrington J, Jaffe HS. Adv Exp Med Biol; 1999 Sep 28; 458():111-20. PubMed ID: 10549383 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]